World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Canada
2023

D-Index & Metrics

Microbiology

D-Index
101
Citations
42100
World Ranking
382
National Ranking
26

Medicine

D-Index
115
Citations
57974
World Ranking
4484
National Ranking
169

Research.com Recognitions

  • 2023 - Research.com Microbiology in Canada Leader Award
  • 2022 - Research.com Microbiology in Canada Leader Award

Overview

Harry L.A. Janssen is affiliated with Erasmus University Rotterdam in the Netherlands and has an extensive publication record in the field of medicine, particularly focusing on liver diseases and hepatology. Their research contributions span multiple interconnected domains including epidemiology, hepatology, surgery, immunology, and infectious diseases.

Their primary areas of study include liver disease diagnosis and treatment, hepatitis B virus studies, hepatitis C virus research, liver diseases and immunity, hepatitis viruses studies and epidemiology, liver disease and transplantation, and gallbladder and bile duct disorders.

Frequent venues for Janssen's work consist of several leading journals in gastroenterology and hepatology:

  • Journal of Hepatology
  • The American Journal of Gastroenterology
  • Hepatology
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology

Janssen has collaborated extensively with a number of co-authors, with frequent collaborations noted with:

  • Bettina E. Hansen
  • Jordan J. Feld
  • Milan J. Sonneveld
  • Willem Pieter Brouwer
  • Robert J. de Knegt

Several of Janssen's recent peer-reviewed papers illustrate their focus on liver-related diseases and treatment outcomes:

  • "aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis" (2020), Journal of Hepatology
  • "Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)" (2021), Gastroenterology
  • "Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase" (2020), The American Journal of Gastroenterology
  • "An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B" (2021), Journal of Hepatology
  • "Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity" (2020), Journal of Hepatology

Their research reflects a strong integration of clinical epidemiology and therapeutic strategies aimed at understanding and managing chronic liver diseases, hepatitis B and C infections, and improving survival strategies. The work includes quantitative risk modeling, treatment target identification, and evaluating post-therapy outcomes in diverse patient populations.

Best Publications

  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

    Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti

  • Treatment of HCV Infection by Targeting MicroRNA

    Harry L A Janssen;Hendrik W Reesink;Eric J Lawitz;Stefan Zeuzem

  • Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

    Harry L A Janssen;Monika van Zonneveld;Hakan Senturk;Stefan Zeuzem

  • The Rotterdam Study: Objectives and design update

    Albert Hofman;Guy G. O. Brusselle;Sarwa Darwish Murad;Cornelia M. van Duijn

  • Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

    Bart J Veldt;E Jenny Heathcote;Heiner Wedemeyer;Juerg Reichen

  • Hepatitis B virus infection

    Man-Fung Yuen;Ding-Shinn Chen;Ding-Shinn Chen;Geoffrey M. Dusheiko;Harry L. A. Janssen

  • Budd–Chiari syndrome: a review by an expert panel

    Harry L.A Janssen;Juan-Carlos Garcia-Pagan;Elwyn Elias;Gilles Mentha

  • Etiology, Management, and Outcome of the Budd-Chiari Syndrome

    Sarwa Darwish Murad;Aurelie Plessier;Manuel Hernandez-Guerra;Federica Margherita Fabris

  • Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

    Felix E. De Jongh;Harry L.A. Janssen;Robert A. De Man;Wim C.J. Hop

  • Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

    Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  • Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

    George V. Papatheodoridis;Henry Lik Yuen Chan;Bettina E. Hansen;Harry L A Janssen;Harry L A Janssen

  • PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

    George Papatheodoridis;George Dalekos;Vana Sypsa;Cihan Yurdaydin

  • Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

    Erik H.C.J. Buster;Hajo J. Flink;Yilmaz Cakaloglu;Krzysztof Simon

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

    Unknown

  • Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.

    Erik H.C.J. Buster;Bettina E. Hansen;George K.K. Lau;Teerha Piratvisuth

  • Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

    Monika van Zonneveld;Pieter Honkoop;Bettina E. Hansen;Hubertus G.M. Niesters

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

    Maria Buti;Edward Gane;Wai Kay Seto;Henry L.Y. Chan

  • Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

    M. van Zonneveld;A. B. van Nunen;H. G. M. Niesters;R. A. de Man

  • The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases

    Jean-Jacques Kiladjian;Francisco Cervantes;Franck W. G. Leebeek;Christophe Marzac

  • Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

    Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth

Frequent Co-Authors

Bettina E. Hansen
Bettina E. Hansen University Health Network
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Solko W. Schalm
Solko W. Schalm Erasmus University Rotterdam
Maria Buti
Maria Buti Instituto de Salud Carlos III
Keith D. Lindor
Keith D. Lindor Arizona State University
Albert Parés
Albert Parés University of Barcelona
Kris V. Kowdley
Kris V. Kowdley Washington State University
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various health and science-related careers, many of which can be pursued through online degrees. For individuals facing unique challenges, including those with past convictions, options like the best associate degrees for felons provide a pathway to re-enter education and build a meaningful career.

Health-focused professions are growing rapidly. For those interested in holistic patient care, pursuing functional medicine NP programs offers specialized knowledge that complements a microbiology background.

Job roles linked to data management and coding are also in high demand. Becoming a certified professional coder can be a lucrative path for those who excel in details and paperwork within health systems.

Another valuable career option is health information management. Earning a health information management degree salary can lead to roles managing medical data, crucial for healthcare efficiency and compliance.

Best Scientists Citing Harry L.A. Janssen

Trending Scientists

Recently Published Articles